| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHPSYC.62.8.829 |
| P698 | PubMed publication ID | 16061760 |
| P50 | author | Carol Tamminga | Q29904486 |
| P2093 | author name string | Edward G Jones | |
| Schahram Akbarian | |||
| Yin Guo | |||
| Stephen P Baker | |||
| William E Bunney | |||
| Rosalinda C Roberts | |||
| Robert C Conley | |||
| Erin Bliven | |||
| Amy C Peranelli | |||
| Lori A Luiz | |||
| Martin G Ruehl | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 829-840 | |
| P577 | publication date | 2005-08-01 | |
| P1433 | published in | JAMA Psychiatry | Q635830 |
| P1476 | title | Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia | |
| P478 | volume | 62 |
| Q34210889 | A role for repressive histone methylation in cocaine-induced vulnerability to stress |
| Q34888915 | Alterations in oligodendrocyte proteins, calcium homeostasis and new potential markers in schizophrenia anterior temporal lobe are revealed by shotgun proteome analysis |
| Q38528430 | An update on the epigenetics of psychotic diseases and autism |
| Q35100274 | Balancing histone methylation activities in psychiatric disorders. |
| Q34619255 | Customizing microarrays for neuroscience drug discovery |
| Q36632924 | DNA methylation in schizophrenia: progress and challenges of epigenetic studies |
| Q45054111 | Differences in 5-HT2A and mGlu2 Receptor Expression Levels and Repressive Epigenetic Modifications at the 5-HT2A Promoter Region in the Roman Low- (RLA-I) and High- (RHA-I) Avoidance Rat Strains. |
| Q37173776 | Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. |
| Q35835236 | Disease- and age-related changes in histone acetylation at gene promoters in psychiatric disorders |
| Q28681777 | Early origins of adult disease: approaches for investigating the programmable epigenome in humans, nonhuman primates, and rodents |
| Q47341920 | Early-Life Social Isolation-Induced Depressive-Like Behavior in Rats Results in Microglial Activation and Neuronal Histone Methylation that Are Mitigated by Minocycline |
| Q34225213 | Effects of histone modifications on increased expression of polyamine biosynthetic genes in suicide |
| Q41789648 | Effects of promoter methylation on increased expression of polyamine biosynthetic genes in suicide |
| Q50588458 | Epigenetic Regulation of Memory-Therapeutic Potential for Disorders. |
| Q35237163 | Epigenetic approaches to psychiatric disorders |
| Q38079160 | Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors |
| Q36001875 | Epigenetic management of major psychosis |
| Q24654169 | Epigenetic mechanisms in schizophrenia |
| Q92453407 | Epigenetic mechanisms in schizophrenia and other psychotic disorders: a systematic review of empirical human findings |
| Q39010677 | Epigenetic mechanisms in the pathophysiology of psychotic disorders |
| Q37087532 | Epigenetic regulation in human brain-focus on histone lysine methylation |
| Q36173922 | Epigenetics of major psychosis: progress, problems and perspectives |
| Q51899107 | Failure to Confirm CNVs as of Aetiological Significance in Twin Pairs Discordant for Schizophrenia |
| Q26744755 | From Linkage Studies to Epigenetics: What We Know and What We Need to Know in the Neurobiology of Schizophrenia |
| Q90294273 | From Schizophrenia Genetics to Disease Biology: Harnessing New Concepts and Technologies |
| Q43199178 | Genetic and epigenetic influences on expression of spermine synthase and spermine oxidase in suicide completers |
| Q28394929 | Growth arrest and DNA-damage-inducible, beta (GADD45b)-mediated DNA demethylation in major psychosis |
| Q36807960 | Histone H3 phosphorylation is upregulated in PBMCs of schizophrenia patients in comparison to healthy controls. |
| Q34682060 | Histone Posttranslational Modifications in Schizophrenia |
| Q24642864 | Histone deactylase 1 expression is increased in the prefrontal cortex of schizophrenia subjects: analysis of the National Brain Databank microarray collection |
| Q24606593 | Histone modifications, DNA methylation, and schizophrenia |
| Q35177686 | Horizons of psychiatric genetics and epigenetics: where are we and where are we heading? |
| Q37686429 | How the epigenome contributes to the development of psychiatric disorders |
| Q24652360 | Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder |
| Q39861509 | Involvement of SMARCA2/BRM in the SWI/SNF chromatin-remodeling complex in schizophrenia |
| Q38138499 | Lysine metabolism in mammalian brain: an update on the importance of recent discoveries. |
| Q31147573 | MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex |
| Q35983577 | Mitochondrial DNA: A Blind Spot in Neuroepigenetics |
| Q37230971 | Prefrontal cortical dysfunction after overexpression of histone deacetylase 1. |
| Q34702215 | Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters |
| Q58549228 | Preterm Birth and the Risk of Neurodevelopmental Disorders - Is There a Role for Epigenetic Dysregulation? |
| Q38925886 | Reciprocal Control of Thyroid Binding and the Pipecolate Pathway in the Brain |
| Q34079415 | Regulation of histone H3K4 methylation in brain development and disease |
| Q53292303 | Repeated treatment with electroconvulsive seizures induces HDAC2 expression and down-regulation of NMDA receptor-related genes through histone deacetylation in the rat frontal cortex. |
| Q33624604 | Rethinking the Epigenetic Framework to Unravel the Molecular Pathology of Schizophrenia |
| Q37358791 | Role of Epigenetics in Biology and Human Diseases. |
| Q34973585 | Schizophrenia proteomics: biomarkers on the path to laboratory medicine? |
| Q38138118 | Suicide and the polyamine system |
| Q30476266 | The HDAC Inhibitor Phenylbutyrate Reverses Effects of Neonatal Ventral Hippocampal Lesion in Rats |
| Q38189293 | The epigenome and postnatal environmental influences in psychotic disorders. |
| Q34236086 | The molecular pathology of schizophrenia--focus on histone and DNA modifications |
| Q38716873 | Understanding the genetic liability to schizophrenia through the neuroepigenome |
Search more.